LOS ANGELES--(BUSINESS WIRE)--Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its ...

In a recent early release Pediatrics journal study, researchers investigate the presence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children between the ages ...

As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests. The team, which was funded by NIH's Rapid Acceleration of ...

LOS ANGELES--(BUSINESS WIRE)--Following a new investment of $6.1 million (NZD $8.8 million), biotech company Pictor today announced a partnership with U.S. laboratory service provider Mobility Health, ...

As fear mounts over the spread of the mysterious flulike illness known as SARS, the most pressing need in the medical world today is not for a new vaccine or treatment, but for a quick test to detect ...

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. have formed a partnership to develop NanoSpot.AI, a fast, easy-to-administer SARS-CoV-2 antibody test. The University of Utah (the ...

There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States. A big concern has been test availability, but test accuracy may prove a larger long-term ...

Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19. FuG1 ...

Tests for the SARS virus will soon help doctors sort out whether people with worrisome coughs and fevers actually have the new respiratory illness, relieving anxiety for many and helping judge who ...

Monoclonal antibodies have been effective in treating in both preventing and treating SARS-CoV-2 infections. However, just as SARS-CoV-2 evolves to evade immune responses by vaccines and natural ...